Literature DB >> 9234417

Economic evaluation of bovine brucellosis and tuberculosis eradication programmes in a mountain area of Spain.

A Bernués1, E Manrique, M T Maza.   

Abstract

We applied social cost-benefit analysis to the economic evaluation of the bovine brucellosis and bovine tuberculosis eradication programmes carried out by the public eradication authority for mountain areas in the Spanish Central Pyrenees. We considered only the effects on animal health and production. We also evaluated several hypotheses corresponding to the different sanitary situations of two valleys studied. The results were different for the two disease programmes. The brucellosis programme was economically efficient over a sufficiently long time frame, but the bovine tuberculosis programme was not. A factor having the greatest influence on the economic efficiency of the programmes was the initial prevalence of the disease in the two valleys studied. The greater this was, the more difficult it was to obtain positive net benefits; this was due the initially high compensation paid for the slaughter of animals testing positive for the disease. The relatively small animal health and production returns derived from the tuberculosis programme explained it's failure to generate positive economic results. The fact that the economic evaluation resulted in unfavourable outcomes is not in itself justification for project termination, because the benefits to the wider community through the prevention of zoonosis were not considered in this analysis.

Entities:  

Mesh:

Year:  1997        PMID: 9234417     DOI: 10.1016/s0167-5877(96)01103-8

Source DB:  PubMed          Journal:  Prev Vet Med        ISSN: 0167-5877            Impact factor:   2.670


  9 in total

1.  Mutant Brucella abortus membrane fusogenic protein induces protection against challenge infection in mice.

Authors:  Job Alves de Souza Filho; Vicente de Paulo Martins; Priscila Carneiro Campos; Juliana Alves-Silva; Nathalia V Santos; Fernanda Souza de Oliveira; Gustavo B Menezes; Vasco Azevedo; Silvio Lorenzo Cravero; Sergio Costa Oliveira
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

2.  Efficacy of dart or booster vaccination with strain RB51 in protecting bison against experimental Brucella abortus challenge.

Authors:  S C Olsen; C S Johnson
Journal:  Clin Vaccine Immunol       Date:  2012-04-11

Review 3.  Brucellosis in low-income and middle-income countries.

Authors:  Matthew P Rubach; Jo E B Halliday; Sarah Cleaveland; John A Crump
Journal:  Curr Opin Infect Dis       Date:  2013-10       Impact factor: 4.915

4.  Immune Response of Calves Vaccinated with Brucella abortus S19 or RB51 and Revaccinated with RB51.

Authors:  Elaine M S Dorneles; Graciela K Lima; Andréa Teixeira-Carvalho; Márcio S S Araújo; Olindo A Martins-Filho; Nammalwar Sriranganathan; Hamzeh Al Qublan; Marcos B Heinemann; Andrey P Lage
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

5.  Epidemiology of brucellosis among cattle in Korea from 2001 to 2011.

Authors:  Hachung Yoon; Oun-Kyong Moon; Soo-Han Lee; Won-Chang Lee; Moon Her; Wooseog Jeong; Suk-Chan Jung; Do-Soon Kim
Journal:  J Vet Sci       Date:  2014-09-17       Impact factor: 1.672

6.  Transmission dynamics and elimination potential of zoonotic tuberculosis in morocco.

Authors:  Mahamat Fayiz Abakar; Hind Yahyaoui Azami; Philipp Justus Bless; Lisa Crump; Petra Lohmann; Mirjam Laager; Nakul Chitnis; Jakob Zinsstag
Journal:  PLoS Negl Trop Dis       Date:  2017-02-02

7.  Protection efficacy of the Brucella abortus ghost vaccine candidate lysed by the N-terminal 24-amino acid fragment (GI24) of the 36-amino acid peptide PMAP-36 (porcine myeloid antimicrobial peptide 36) in murine models.

Authors:  Ae Jeong Kwon; Ja Young Moon; Won Kyong Kim; Suk Kim; Jin Hur
Journal:  J Vet Med Sci       Date:  2016-06-25       Impact factor: 1.267

8.  The prevalence of brucellosis and bovine tuberculosis in ruminants in Sidi Kacem Province, Morocco.

Authors:  Hind Yahyaoui Azami; Marie J Ducrotoy; Mohammed Bouslikhane; Jan Hattendorf; Mike Thrusfield; Raquel Conde-Álvarez; Ignacio Moriyón; Amaia Zúñiga-Ripa; Pilar M Muñoz Álvaro; Virginie Mick; Ward Bryssinckx; Sue C Welburn; Jakob Zinsstag
Journal:  PLoS One       Date:  2018-09-18       Impact factor: 3.240

9.  Tulathromycin treatment does not affect bacterial dissemination or clearance of Brucella melitensis 16M following experimental infection of goats.

Authors:  Paola M Boggiatto; Steven C Olsen
Journal:  PLoS One       Date:  2019-12-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.